Our commitment to innovation and patients starts with our experienced leadership team. With industry insights, they are empowered to make novel therapeutic biologics in areas where patients need most.

Our R&D team is lead by our executive Director, chief executive officer and chief scientific officer Dr. YIN Liusong. The executive Director and vice president overseeing our research and development is Ms. JIANG Xiaoling. Members of our experienced in-house R&D team come from a variety of medical backgrounds and has diverse and in-depth knowledge that is critical to strengthening our R&D capabilities. The functions of our integrated R&D team span drug discovery, in vitro evaluation, pharmacology and pharmacodynamics, protein engineering, process development and quality analysis.